Abstract

Toll-like-receptor mediated signaling is finely regulated by a complex intracellular protein network including the interleukin-1 receptor associate kinases (IRAKs). IRAK-4, 1, and 2 may positively regulate innate immunity signaling through the activation of various downstream kinases such as MAPKs. In contrast, IRAK-M plays an inhibitory role through unknown mechanism. In this report, we show that IRAK-M is ubiquitously present in the cell, and becomes exclusively cytoplasmic upon bacterial lipoprotein Pam 3CSK 4 challenge. Furthermore, using bone marrow derived macrophages (BMDM) from wild type, IRAK1 −/−, and IRAK-M −/− mice, we have herein demonstrated that IRAK-M selectively attenuates bacterial lipopeptide Pam 3CSK 4-induced p38 activation, but not ERK or JNK. IRAK1 −/− and IRAK-M −/−BMDM display distinct activation profile of various MAP kinases upon Pam 3CSK 4 challenge, indicating that IRAK-M exerts its inhibitory effect through an IRAK1 independent pathway. Pam 3CSK 4 challenge leads to rapid decrease of MKP-1 protein level in IRAK-M −/−BMDM as well as THP-1 cells with decreased IRAK-M expression through siRNA interference. Our findings indicate that IRAK-M selectively attenuates p38 activation and inhibits innate immunity through stabilizing MKP-1.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.